Back To: Home : Featured Technology : Functional Genomic Screening

CLICK HERE FOR WHAT'S NEW IN:
 

MultiCell Technologies, Anthony Altig, Director
10-24-2005
SHARING OPTIONS:

LINCOLN, R.I.óMultiCell Technologies Inc., an adult stem cell company and supplier of immortalized non-tumorigenic human hepatocytes for drug discovery, announced today that it has appointed Anthony Altig to the company's board of directors.
 
Altig has extensive experience in financial management, strategic planning and SEC reporting, as well as investor relations, budgeting, treasury, tax planning and risk management. His 23 years of experience with biotech and technology companies include public and debt financing transactions, financial operations, strategic alliances, mergers and acquisitions. Altig is currently Senior Vice President and chief financial officer for Diversa Corp. a leader in applying proprietary genomic technologies for the rapid discovery and optimization of novel protein-based products. Altig previously was the chief financial officer of Maxim Pharmaceuticals Inc.

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.